1. Home
  2. EVTC vs GENB Comparison

EVTC vs GENB Comparison

Compare EVTC & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$31.38

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.40

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EVTC
GENB
Founded
1988
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2013
2026

Fundamental Metrics

Financial Performance
Metric
EVTC
GENB
Price
$31.38
$15.40
Analyst Decision
Hold
Strong Buy
Analyst Count
5
6
Target Price
$35.80
$23.20
AVG Volume (30 Days)
382.6K
484.7K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
0.67%
N/A
EPS Growth
27.17
N/A
EPS
0.47
N/A
Revenue
$453,869,000.00
N/A
Revenue This Year
$12.68
N/A
Revenue Next Year
$6.86
$16.58
P/E Ratio
$64.70
N/A
Revenue Growth
11.48
N/A
52 Week Low
$21.81
$11.00
52 Week High
$37.38
$18.18

Technical Indicators

Market Signals
Indicator
EVTC
GENB
Relative Strength Index (RSI) 58.40 58.75
Support Level $27.98 $11.82
Resistance Level $34.41 $16.75
Average True Range (ATR) 1.31 0.82
MACD -0.18 0.17
Stochastic Oscillator 46.43 94.98

Price Performance

Historical Comparison
EVTC
GENB

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: